5 results on '"Jessica L. Barrington-Trimis"'
Search Results
2. Failed Attempts to Quit Combustible Cigarettes and e-Cigarettes Among US Adolescents
- Author
-
Richard, Miech, Adam M, Leventhal, Patrick M, O'Malley, Lloyd D, Johnston, and Jessica L, Barrington-Trimis
- Subjects
Adolescent ,Humans ,Smoking Cessation ,Tobacco Products ,General Medicine ,Electronic Nicotine Delivery Systems ,United States ,Article ,Cigarette Smoking - Published
- 2022
3. Flavors of e-Cigarettes Used by Youths in the United States
- Author
-
Patrick M. O'Malley, Richard A. Miech, Megan E. Patrick, Adam M. Leventhal, Lloyd D. Johnston, and Jessica L. Barrington-Trimis
- Subjects
Medical education ,Adolescent ,business.industry ,Vaping ,010102 general mathematics ,MEDLINE ,Survey research ,General Medicine ,Electronic Nicotine Delivery Systems ,01 natural sciences ,United States ,Flavoring Agents ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Research Letter ,Government Regulation ,Humans ,Medicine ,030212 general & internal medicine ,0101 mathematics ,Child ,business - Abstract
This national survey study characterizes JUUL e-cigarette flavors (mint, mango, fruit, and others) most often used by US middle school and high school students in 2019.
- Published
- 2019
4. Association of e-Cigarette Vaping and Progression to Heavier Patterns of Cigarette Smoking
- Author
-
Adam M. Leventhal, Matthew D. Stone, Steve Sussman, Nafeesa Andrabi, Jessica L. Barrington-Trimis, David R. Strong, and Janet Audrain-McGovern
- Subjects
Male ,Nicotine ,Adolescent ,Chain smoking ,medicine.medical_treatment ,MEDLINE ,030508 substance abuse ,Electronic Nicotine Delivery Systems ,Article ,03 medical and health sciences ,0302 clinical medicine ,Cigarette smoking ,Risk Factors ,Environmental health ,Odds Ratio ,medicine ,Humans ,030212 general & internal medicine ,Pack-year ,Students ,Extramural ,business.industry ,Data Collection ,Smoking ,Tobacco Products ,General Medicine ,Ganglionic Stimulants ,Los Angeles ,Adolescent Behavior ,Smoking cessation ,Female ,Self Report ,0305 other medical science ,business ,Follow-Up Studies - Abstract
Exposure to nicotine in electronic cigarettes (e-cigarettes) is becoming increasingly common among adolescents who report never having smoked combustible tobacco.To evaluate whether e-cigarette use among 14-year-old adolescents who have never tried combustible tobacco is associated with risk of initiating use of 3 combustible tobacco products (ie, cigarettes, cigars, and hookah).Longitudinal repeated assessment of a school-based cohort at baseline (fall 2013, 9th grade, mean age = 14.1 years) and at a 6-month follow-up (spring 2014, 9th grade) and a 12-month follow-up (fall 2014, 10th grade). Ten public high schools in Los Angeles, California, were recruited through convenience sampling. Participants were students who reported never using combustible tobacco at baseline and completed follow-up assessments at 6 or 12 months (N = 2530). At each time point, students completed self-report surveys during in-classroom data collections.Student self-report of whether he or she ever used e-cigarettes (yes or no) at baseline.Six- and 12-month follow-up reports on use of any of the following tobacco products within the prior 6 months: (1) any combustible tobacco product (yes or no); (2) combustible cigarettes (yes or no), (3) cigars (yes or no); (4) hookah (yes or no); and (5) number of combustible tobacco products (range: 0-3).Past 6-month use of any combustible tobacco product was more frequent in baseline e-cigarette ever users (n = 222) than never users (n = 2308) at the 6-month follow-up (30.7% vs 8.1%, respectively; difference between groups in prevalence rates, 22.7% [95% CI, 16.4%-28.9%]) and at the 12-month follow-up (25.2% vs 9.3%, respectively; difference between groups, 15.9% [95% CI, 10.0%-21.8%]). Baseline e-cigarette use was associated with greater likelihood of use of any combustible tobacco product averaged across the 2 follow-up periods in the unadjusted analyses (odds ratio [OR], 4.27 [95% CI, 3.19-5.71]) and in the analyses adjusted for sociodemographic, environmental, and intrapersonal risk factors for smoking (OR, 2.73 [95% CI, 2.00-3.73]). Product-specific analyses showed that baseline e-cigarette use was positively associated with combustible cigarette (OR, 2.65 [95% CI, 1.73-4.05]), cigar (OR, 4.85 [95% CI, 3.38-6.96]), and hookah (OR, 3.25 [95% CI, 2.29-4.62]) use and with the number of different combustible products used (OR, 4.26 [95% CI, 3.16-5.74]) averaged across the 2 follow-up periods.Among high school students in Los Angeles, those who had ever used e-cigarettes at baseline compared with nonusers were more likely to report initiation of combustible tobacco use over the next year. Further research is needed to understand whether this association may be causal.
- Published
- 2016
5. Flavorings in Electronic Cigarettes
- Author
-
Rob McConnell, Jessica L. Barrington-Trimis, and Jonathan M. Samet
- Subjects
Lung Diseases ,Risk ,Public Policy ,Flavoring Agents ,Electronic Nicotine Delivery Systems ,Article ,Occupational safety and health ,law.invention ,chemistry.chemical_compound ,law ,Environmental health ,Generally recognized as safe ,Humans ,Medicine ,Occupational exposure limit ,Inhalation Exposure ,Harm reduction ,United States Food and Drug Administration ,business.industry ,food and beverages ,General Medicine ,equipment and supplies ,Diacetyl ,Hazard ,United States ,chemistry ,business ,Electronic cigarette - Abstract
Use of electronic cigarettes (e-cigarettes), vape pens, e-hookah, e-cigars, e-pipes, or other electronic nicotine delivery systems (ENDS) has increased rapidly since their introduction in the United States in 2007, growing to a $2 billion market.1 There is controversy concerning the utility of ENDS as a harm reduction strategy, reflecting major gaps in the emerging evidence on potential benefits and harms of the products.2-4 Although exclusive use of ENDS is generally considered to be less risky for individuals than smoking combustible tobacco products, there is concern that their availability may both lead to dual product use (ie, ENDS and cigarettes) and reduce cessation. Additionally, there is concern that ENDS may be used by nonsmoking adolescents and young adults who might not otherwise have used nicotine-delivering products, and that dual use may follow. Numerous flavored products that have seeming appeal to adolescents and young adults are on the market, such as Cherry Crush, Chocolate Treat, Snappin' Apple, and Vanilla Dreams flavors; their availability may generate an entirely new population of nicotine-addicted users among never-users of combustible tobacco products. Given the limited timespan over which these products have been in the marketplace, the long-term safety of ENDS is uncertain. One concern that has received little attention is the potential for toxic effects from inhaled flavorings. To date, research on pulmonary toxicity has focused largely on the nicotine-containing solution (e-liquid) vaporized by ENDS, composed in most products of some combination of propylene glycol, vegetable glycerin, nicotine, and flavorings.2 Recent in vitro studies found that the cytotoxic effects of e-liquids were largely restricted to flavoring components.2 The diversity of ENDS products, in particular of flavorings, is also increasing at a rapid rate. As of January 2014,there were 466 distinct brands of electronic nicotine products and at least 7764 unique flavors, an increase of about 10.5 brands and 242 new flavor products per month from August 2013 to January 2014.1 In addition, many users may create their own mixtures of flavorings by combining different flavors or by using flavoring available directly from food flavoring manufacturers to create unique flavors. Flavorings are a largely unrecognized potential hazard of ENDS, which are designed to create an ultrafine aerosol that penetrates deeply into the lungs. Respiratory toxins in flavorings thus may pose a threat to the respiratory health of users. The Flavor and Extract Manufacturers Association evaluates the safety of chemicals used in food flavorings, many of which also may be used in ENDS. However, the association's research is limited to the evaluation of the safety of chemicals in food (for ingestion), and as such, ENDS flavorings using the same chemicals cannot be also be deemed “generally recognized as safe” for inhalation.5 For example, the chemical diacetyl (2,3-butanedione) is used to give foods a buttery or creamy flavor. High doses of diacetyl, deemed safe for ingestion by the Flavor and Extract Manufacturers Association and the US Food and Drug Administration (FDA), have been shown to cause acute-onset bronchiolitis obliterans, a severe and irreversible obstructive lung disease, when inhaled by workers exposed to particulate aerosolized flavorings containing diacetyl. Bronchiolitis obliterans was originally recognized as “popcorn lung” in an outbreak among flavor manufacturing workers at a microwave popcorn production plant, caused by inhalation of diacetyl in popcorn butter flavorings.6 There is currently no enforceable workplace standard specific to diacetyl. The National Institute for Occupational Safety and Health at the Centers for Disease Control and Prevention has recommended an 8-hour time-weighted occupational exposure limit of 5 ppb. In light of research on the adverse effects of diacetyl inhalation, other diketone flavorings (eg, 2,3-pentanedione, 2,3-hexanedione, and 2,3-heptanedione) have been used as flavoring substitutes for diacetyl. However, some research suggests that these diketone substitutes may be as toxic to the lung as diacetyl.7 A recent evaluation of 159 sweet-flavored ENDS solutions found diacetyl in 69.2% of samples and in at least 1 sample from 92% of manufacturers8; 2,3-pentanedione was found in one-third of samples. The investigators estimated the daily inhaled exposure to diacetyl and 2,3-pentanedione among users of 3 mL per day of ENDS refill solution (or diluted flavoring solution), and concluded that 47.3% of diacetyl- and 41.5% of 2,3-pentanedione–containing solutions resulted in exposures exceeding the National Institute for Occupational Safety and Health– recommended standard.8 The potential hazards of ENDS flavorings are not limited to diacetyl and its substitutes. Flavorings may also contain other chemicals used in food flavorings that are considered safe for ingestion but not for inhalation. In 2012, the Flavor and Extract Manufacturers Association issued a report that lists 27 high-priority flavoring substances to be evaluated for permissible respiratory exposure limits in the workplace, based on adverse respiratory toxic effects. These included diacetyl and diacetyl substitutes, and other chemicals that may be added to ENDS or may be by-products of the manufacturing process.9 The potential for respiratory effects in ENDS users is of concern to the association, which recently released a reminder that the primary safety assessment programs for flavors are restricted to flavorings used in human foods, and that “e-cigarette manufacturers should not represent or suggest that the flavor ingredients used in their products are safe because they have FEMA [Flavor and Extract Manufacturers Association] ‘generally recognized as safe’ status for use in food because such statements are false and misleading.”5 ENDS online user groups have also expressed concern about the potential health effects of diacetyl in flavorings. However, the potential respiratory hazards of flavorings are largely absent from the public health and regulatory agenda, which has primarily focused on the use of flavors to appeal to youth as part of aggressive industry marketing, and the resulting risk of nicotine addiction in adolescent populations. A recent position statement on ENDS by the Forum of International Respiratory Societies contained one line on the potential hazards of flavorings. To our knowledge, there has only recently been one published analysis of diacetyl and 2,3-pentanedioneinENDSflavorings and little analysis of other potential respiratory toxins, and there has not been sufficient time to conduct an epidemiologic study to understand the association between use of ENDS flavorings and adverse respiratory health effects in human populations. At present, there is no jurisdiction to regulate the composition of e-liquids, no regulatory program to assess the hazards of the flavorings in ENDS products, and no surveillance system in place to identify ENDS users with severe respiratory disease. The proposed Deeming Regulations of the FDA, which would extend the agency's authority to regulate products meeting the statutory definition of “tobacco products” (including ENDS), only propose to restrict the sale of flavored ENDS to minors. There is no proposed regulation of the composition of ENDS flavorings based on respiratory health effects, in part due to the lack of available research on the toxic and adverse health effects of ENDS flavorings. Research is needed to characterize both the presence of toxic chemicals in ENDS flavorings and the potential adverse respiratory effects of exposure to e-liquids, especially flavorings. In the meantime, regardless of the potential long-term harm reduction benefits of ENDS, an important policy question is whether the still uncertain risk of potentially serious lung disease merits precautionary regulation of e-liquid composition in the face of considerable scientific uncertainty.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.